ResMed announces results for the second quarter of fiscal year 2018
ResMed reported net income for the 2018 second quarter was $9.5 million, an 88 percent decrease compared to the same period of the prior year. Cash flow from operations for the 2018 second quarter was $132.6 million versus net income in the current quarter of $9.5 million. January 22, 2018